-
Arsenic Neurotoxicity, BBB Breakdown, and MMP-2/9
2026-08-18
This study links sodium arsenite–induced learning and memory deficits in male mice to MMP-2/MMP-9-associated blood–brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its doxycycline intervention provides pharmacological evidence that preserving BBB integrity may mitigate arsenic-related cognitive dysfunction, while also highlighting the limits of inferring target-specific causality from a pleiotropic MMP inhibitor.
-
Cyclophosphamide: Applied Cancer Research Workflows
2026-08-18
Cyclophosphamide is an alkylating chemotherapeutic agent that supports apoptosis induction in cancer cells, immune-modulation studies, and bone marrow transplantation conditioning models. This workflow-focused guide explains activation-aware experimental design, reproducible dosing, assay selection, and troubleshooting for cancer research.
-
Dasatinib: A Context-First Kinase Research Guide
2026-08-17
Dasatinib (BMS-354825) is a powerful Src-family and Bcr-Abl kinase probe. This guide develops a context-first strategy for connecting kinase inhibition with FAK signaling, EMT, stemness, and metastatic phenotypes without overstating evidence from thymic tumor research.
-
Rapamycin, Autophagy, and Lipotoxicity in Salmon Cells
2026-08-17
Phadwal et al. developed a cell-based Atlantic salmon model showing that rapamycin-induced autophagy promotes lipid-droplet breakdown and reduces features of lipotoxicity. Integrated lipidomics and proteomics linked this response to altered triacylglycerol storage, suppression of lipogenic proteins, and possible autophagic targeting of Elovl6 and Fabp2.
-
WSP-5 for Live-Cell H2S Imaging
2026-08-16
WSP-5 converts fast, low-abundance hydrogen sulfide signals into a turn-on fluorescence readout for live-cell imaging, donor-release studies, and disease models. This workflow-focused guide shows how to connect H2S imaging with the lipotoxicity and ER-stress findings reported in diabetic cardiomyopathy research while avoiding common assay artifacts.
-
JEV NS4B Disrupts Lysosomes Through LAMP1/2 Loss
2026-08-15
The 2024 Veterinary Microbiology study identifies JEV NS4B as a viral determinant that activates ER stress-related autophagy while reducing LAMP1 and LAMP2, thereby impairing lysosomal acidification and catabolism. Its mapping of the NS4B 131–204 amino acid region provides a focused framework for studying how flavivirus proteins remodel the autophagy–lysosome system and alter SLA-DR handling.
-
SMAD3 Inhibition and ADAMTS-5 in Early OA
2026-08-14
Xiang et al. identify a regulatory link between SMAD3, miRNA-140, and ADAMTS-5 in early osteoarthritis. Their combined cell and animal experiments suggest that pharmacological SMAD3 inhibition can suppress a cartilage-degrading enzyme before prominent structural deterioration is detectable, while also defining important limits for interpreting SIS3-based studies.
-
B. fragilis, Gut-Brain Cholinergic Signaling, and Seizures
2026-08-14
Jia et al. identify a gut–vagus–brain cholinergic circuit through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells, vagal transmission, and enriched Lactobacillus colonization. Mouse experiments, circuit-level interventions, and a randomized pediatric clinical trial provide a translational framework for microbiota-targeted research in refractory epilepsy.
-
Optimizing Calcium Phosphate Transfection
2026-08-13
This study identifies the DNA-to-reaction-volume balance as the central determinant of calcium phosphate transfection efficiency in HEK 293T cells. Its optimized condition, 80 µg plasmid DNA in 1 mL for 2–3 × 10⁵ cells/mL, provides a practical benchmark for improving an inexpensive alternative to polymeric and lipid-based reagents.
-
Wnt/NR2F2 Drives Platinum Resistance in Brain Metastasis
2026-08-13
The reference study shows that lung cancer-derived brain metastatic cells acquire platinum resistance through high glutathione consumption, coordinated GPX4/GSTM1 activity, and suppression of ferroptosis. Its mechanistic link between Wnt/NR2F2 signaling and GPX4 transcription identifies a redox vulnerability that may inform combination-treatment and pathway-perturbation studies.
-
Naloxone Hydrochloride: A Translational Research Tool
2026-08-12
Naloxone hydrochloride is more than a familiar rescue pharmacology reagent. Its receptor blockade, receptor-independent effects on neural stem cells, and context-sensitive immune and behavioral activity make it a valuable tool for mechanism-defined translational research.
-
Renal OCT2/MATE1 Inhibition by 5-HT3 Antagonists
2026-08-12
George and colleagues systematically compared five 5-HT3 antagonist antiemetics for inhibition of renal OCT2 and MATE1, combining transporter-specific uptake assays with a polarized epithelial transport model. The results identify compound- and transporter-dependent inhibition patterns that may help researchers interpret renal drug–drug interaction risk for organic cation substrates.
-
Baricitinib for JAK1/2 Inflammation Assays
2026-08-11
Baricitinib (LY3009104) provides a selective way to interrogate JAK1/2-driven cytokine signaling in epithelial–immune models. This guide translates spatial proteomics findings on PD-L1–IL-6 crosstalk into practical assay workflows, controls, and troubleshooting strategies for inflammatory disease research.
-
Metoprolol Tartrate: A β1 Assay Design Guide
2026-08-11
Metoprolol Tartrate is a selective β1-adrenergic blocking agent for separating cardiac β1 signaling from broader adrenergic effects. This guide translates recent hematopoietic-regeneration evidence into practical assay controls, concentration logic, and cross-domain interpretation.
-
Novel Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-10
The reference study developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent lead with activity in biochemical and mouse models. Its integrated medicinal chemistry, pharmacokinetic, metabolic, allergy, and cancer experiments provide a useful preclinical framework while leaving important questions about selectivity, mechanism, and clinical translation unresolved.